Vaxart, Inc. (VXRT)
OTCMKTS · Delayed Price · Currency is USD
0.50165
-0.00165 (-0.33%)
At close: Aug 28, 2026
Vaxart Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 243.07 | 237.26 | 28.7 | 7.38 | 0.11 | 0.89 | |
Revenue Growth | 201.11% | 726.68% | 288.94% | 6796.26% | -88.00% | -77.95% |
Cost of Revenue | 184.26 | 201.58 | 74.21 | 68.14 | 81.05 | 48.75 |
Gross Profit | 58.8 | 35.68 | -45.51 | -60.76 | -80.95 | -47.86 |
Selling, General & Admin | 19.19 | 17.61 | 20.78 | 22.58 | 29.39 | 21.89 |
Operating Expenses | 19.19 | 17.61 | 20.78 | 22.58 | 29.39 | 21.89 |
Operating Income | 39.61 | 18.07 | -66.29 | -83.35 | -110.33 | -69.75 |
Interest Expense | -2.2 | -2.82 | -2.97 | -1.45 | -1.31 | -1.48 |
Interest & Investment Income | 1.98 | 1.6 | 2.54 | 2.65 | 1.25 | 0.08 |
Currency Exchange Gain (Loss) | - | - | - | - | - | -0 |
Other Non Operating Income (Expenses) | -0.39 | -0.04 | 0.03 | -0.06 | -0.01 | - |
EBT Excluding Unusual Items | 39.01 | 16.8 | -66.69 | -82.2 | -110.4 | -71.15 |
Asset Writedown | - | - | - | - | -4.25 | -3.01 |
Other Unusual Items | - | - | - | - | 6.96 | 3.79 |
Pretax Income | 39.01 | 16.8 | -66.69 | -82.2 | -107.69 | -70.36 |
Income Tax Expense | 0.42 | 0.48 | 0.26 | 0.26 | 0.07 | 0.11 |
Net Income | 38.59 | 16.33 | -66.95 | -82.47 | -107.76 | -70.47 |
Net Income to Common | 38.59 | 16.33 | -66.95 | -82.47 | -107.76 | -70.47 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 237 | 230 | 202 | 145 | 128 | 121 |
Shares Outstanding (Diluted) | 237 | 230 | 202 | 145 | 128 | 121 |
Shares Change | 4.01% | 13.96% | 39.58% | 13.42% | 5.13% | 37.55% |
EPS (Basic) | 0.16 | 0.07 | -0.33 | -0.57 | -0.84 | -0.58 |
EPS (Diluted) | 0.16 | 0.07 | -0.33 | -0.57 | -0.84 | -0.58 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 33.38 | 7.57 | -45.32 | -72.32 | -104.38 | -64.99 |
Free Cash Flow Per Share | 0.14 | 0.03 | -0.22 | -0.50 | -0.82 | -0.54 |
Gross Margin | 24.19% | 15.04% | -158.58% | - | - | - |
Operating Margin | 16.30% | 7.62% | -230.99% | -1129.52% | -103114.95% | -7819.17% |
Profit Margin | 15.88% | 6.88% | -233.27% | -1117.56% | -100708.41% | -7900.22% |
Free Cash Flow Margin | 13.73% | 3.19% | -157.90% | -980.13% | -97551.40% | -7285.76% |
EBITDA | 45.62 | 26.65 | -57.44 | -74.72 | -104.53 | -65.54 |
EBITDA Margin | 18.77% | 11.23% | -200.15% | - | - | - |
D&A For EBITDA | 6 | 8.58 | 8.85 | 8.62 | 5.81 | 4.21 |
EBIT | 39.61 | 18.07 | -66.29 | -83.35 | -110.33 | -69.75 |
EBIT Margin | 16.30% | 7.62% | -230.99% | - | - | - |
Effective Tax Rate | 1.07% | 2.83% | - | - | - | - |
Revenue as Reported | 243.07 | 237.26 | 28.7 | 7.38 | 0.11 | 0.89 |